Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Community-based, Controlled, Open-label, Cluster-randomized Trial for the Reduction of Chronic Malnutrition in Children Under Two Years of Age, With Three Intervention Arms Grouped by Clusters, in Two Provinces in Southern Angola, Huíla and Cunene. 10/07/2022 INTERVENTIONAL not-comparable 1,464.75 0 Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis 10/07/2022 INTERVENTIONAL not-comparable 1,464.75 0 The Rechallenge of ADCs in MBC Patients 10/07/2022 OBSERVATIONAL not-comparable 1,464.75 0 Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer 10/10/2022 INTERVENTIONAL not-comparable 1,461.75 0 Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype 10/10/2022 OBSERVATIONAL not-comparable 1,461.75 0 Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) 10/12/2022 OBSERVATIONAL not-comparable 1,459.75 0 Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study 10/12/2022 INTERVENTIONAL not-comparable 1,459.75 0 STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision 10/13/2022 INTERVENTIONAL not-comparable 1,458.75 0 Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial 10/13/2022 INTERVENTIONAL not-comparable 1,458.75 0 A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding 10/14/2022 OBSERVATIONAL not-comparable 1,457.75 0 PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer 10/14/2022 INTERVENTIONAL not-comparable 1,457.75 0 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy 10/17/2022 INTERVENTIONAL not-comparable 1,454.75 0 Engage & Connect: A Psychotherapy for Postpartum Depression 10/18/2022 INTERVENTIONAL not-comparable 1,453.75 0 A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients. 10/18/2022 INTERVENTIONAL not-comparable 1,453.75 0 Pulsed Lavage in Implant-Based Breast Reconstruction 10/19/2022 INTERVENTIONAL not-comparable 1,452.75 0 Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP) 10/19/2022 INTERVENTIONAL not-comparable 1,452.75 0 Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy 10/19/2022 INTERVENTIONAL not-comparable 1,452.75 0 Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension 10/19/2022 OBSERVATIONAL not-comparable 1,452.75 0 A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer 10/20/2022 INTERVENTIONAL not-comparable 1,451.75 0 Monitoring of Chronic Conditions in Breast Cancer 10/20/2022 OBSERVATIONAL not-comparable 1,451.75 0 Efficacy of Mobile Health Application in Promotion of Exclusive Breast Feeding and Young Child Feeding Practices in Pakistan 10/21/2022 INTERVENTIONAL not-comparable 1,450.75 0 Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors 10/21/2022 OBSERVATIONAL not-comparable 1,450.75 0 Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen 10/24/2022 INTERVENTIONAL not-comparable 1,447.75 0 Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) 10/25/2022 INTERVENTIONAL not-comparable 1,446.75 0 SNF Platform Study of HR+/ HER2-advanced Breast Cancer 10/26/2022 INTERVENTIONAL not-comparable 1,445.75 0 Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors 10/27/2022 INTERVENTIONAL not-comparable 1,444.75 0 Perinatal Research on Improving Sleep and Mental Health 10/27/2022 INTERVENTIONAL not-comparable 1,444.75 0 REBOA in Life-threatening Postpartum Hemorrhage (PPH) in Uganda 10/28/2022 INTERVENTIONAL not-comparable 1,443.75 0 LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema 11/01/2022 INTERVENTIONAL not-comparable 1,439.75 0 Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) 11/01/2022 INTERVENTIONAL not-comparable 1,439.75 0 ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) 11/01/2022 INTERVENTIONAL not-comparable 1,439.75 0 TARGETing Healthy Weight Loss in the Context of Food Insecurity 11/01/2022 OBSERVATIONAL not-comparable 1,439.75 0 Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS 11/02/2022 INTERVENTIONAL not-comparable 1,438.75 0 A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN) 11/02/2022 INTERVENTIONAL not-comparable 1,438.75 0 Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma 11/03/2022 INTERVENTIONAL not-comparable 1,437.75 0 Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women 11/03/2022 INTERVENTIONAL not-comparable 1,437.75 0 Healthier At-home Meals for Expectant Mothers 11/04/2022 INTERVENTIONAL not-comparable 1,436.75 0 Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer 11/04/2022 INTERVENTIONAL not-comparable 1,436.75 0 Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers 11/04/2022 INTERVENTIONAL not-comparable 1,436.75 0 A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study) 11/07/2022 INTERVENTIONAL not-comparable 1,433.75 0 Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) 11/07/2022 INTERVENTIONAL not-comparable 1,433.75 0 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer 11/07/2022 INTERVENTIONAL not-comparable 1,433.75 0 Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial 11/07/2022 INTERVENTIONAL not-comparable 1,433.75 0 Continuous And Data-drivEN CarE (CADENCE) Pilot 11/08/2022 INTERVENTIONAL not-comparable 1,432.75 0 Combination Therapy for Recurrent Ovarian Cancer 11/09/2022 INTERVENTIONAL not-comparable 1,431.75 0 Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients 11/10/2022 OBSERVATIONAL not-comparable 1,430.75 0 Confounding Factors of Chronic Endometritis in Women With Reproductive Failure 11/14/2022 OBSERVATIONAL not-comparable 1,426.75 0 Primary Cervical Cancer Screening by Self-sampling HPV Test 11/14/2022 OBSERVATIONAL not-comparable 1,426.75 0 Neurofeedback During Eating for Bulimia Nervosa 11/14/2022 INTERVENTIONAL not-comparable 1,426.75 0 Postpartum Intervention for Mothers With Opioid Use Disorders 11/14/2022 INTERVENTIONAL not-comparable 1,426.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology